Literature DB >> 27336915

Cystic Fibrosis Lung Immunity: The Role of the Macrophage.

Emanuela M Bruscia1, Tracey L Bonfield.   

Abstract

Cystic fibrosis (CF) pathophysiology is hallmarked by excessive inflammation and the inability to efficiently resolve lung infections, contributing to major morbidity and eventually the mortality of patients with this disease. Macrophages (MΦs) are major players in lung homeostasis through their diverse contributions to both the innate and adaptive immune networks. The setting of MΦ function and activity in CF is multifaceted, encompassing the response to the unique environmental cues in the CF lung as well as the intrinsic changes resulting from CFTR dysfunction. The complexity is further enhanced with the identification of modifier genes, which modulate the CFTR contribution to disease, resulting in epigenetic and transcriptional shifts in MΦ phenotype. This review focuses on the contribution of MΦ to lung homeostasis, providing an overview of the diverse literature and various perspectives on the role of these immune guardians in CF.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27336915      PMCID: PMC5089923          DOI: 10.1159/000446825

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  101 in total

1.  Altered cholesterol homeostasis in cultured and in vivo models of cystic fibrosis.

Authors:  Nicole M White; Dechen Jiang; James D Burgess; Ilya R Bederman; Stephen F Previs; Thomas J Kelley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-11-03       Impact factor: 5.464

2.  Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk.

Authors:  Xingguang Liu; Zhenzhen Zhan; Dong Li; Li Xu; Feng Ma; Peng Zhang; Hangping Yao; Xuetao Cao
Journal:  Nat Immunol       Date:  2011-03-27       Impact factor: 25.606

Review 3.  Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors.

Authors:  Surya Pandey; Taro Kawai; Shizuo Akira
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-10-09       Impact factor: 10.005

4.  Ivacaftor-Induced Proteomic Changes Suggest Monocyte Defects May Contribute to the Pathogenesis of Cystic Fibrosis.

Authors:  Katherine B Hisert; Kelly Q Schoenfelt; Gordon Cooke; Brenda Grogan; Jan L Launspach; Charles G Gallagher; Seamas C Donnelly; Michael J Welsh; Pradeep K Singh; Edward F McKone; Lev Becker
Journal:  Am J Respir Cell Mol Biol       Date:  2016-04       Impact factor: 6.914

5.  Pancreatic damage in fetal and newborn cystic fibrosis pigs involves the activation of inflammatory and remodeling pathways.

Authors:  Maisam Abu-El-Haija; Shyam Ramachandran; David K Meyerholz; Marwa Abu-El-Haija; Michelle Griffin; Radhamma L Giriyappa; David A Stoltz; Michael J Welsh; Paul B McCray; Aliye Uc
Journal:  Am J Pathol       Date:  2012-06-08       Impact factor: 4.307

6.  Increased elastase secretion by peripheral blood monocytes in cystic fibrosis patients.

Authors:  M M Jones; D K Seilheimer; G B Pier; R D Rossen
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

7.  Decreased expression of peroxisome proliferator activated receptor gamma in cftr-/- mice.

Authors:  Mario Ollero; Omer Junaidi; Munir M Zaman; Iphigenia Tzameli; Adolfo A Ferrando; Charlotte Andersson; Paola G Blanco; Eldad Bialecki; Steven D Freedman
Journal:  J Cell Physiol       Date:  2004-08       Impact factor: 6.384

8.  Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2.

Authors:  Fred A Wright; Lisa J Strug; Vishal K Doshi; Clayton W Commander; Scott M Blackman; Lei Sun; Yves Berthiaume; David Cutler; Andreea Cojocaru; J Michael Collaco; Mary Corey; Ruslan Dorfman; Katrina Goddard; Deanna Green; Jack W Kent; Ethan M Lange; Seunggeun Lee; Weili Li; Jingchun Luo; Gregory M Mayhew; Kathleen M Naughton; Rhonda G Pace; Peter Paré; Johanna M Rommens; Andrew Sandford; Jaclyn R Stonebraker; Wei Sun; Chelsea Taylor; Lori L Vanscoy; Fei Zou; John Blangero; Julian Zielenski; Wanda K O'Neal; Mitchell L Drumm; Peter R Durie; Michael R Knowles; Garry R Cutting
Journal:  Nat Genet       Date:  2011-05-22       Impact factor: 38.330

Review 9.  PPARγ and the Innate Immune System Mediate the Resolution of Inflammation.

Authors:  Amanda Croasdell; Parker F Duffney; Nina Kim; Shannon H Lacy; Patricia J Sime; Richard P Phipps
Journal:  PPAR Res       Date:  2015-12-02       Impact factor: 4.964

Review 10.  Alveolar macrophages: plasticity in a tissue-specific context.

Authors:  Tracy Hussell; Thomas J Bell
Journal:  Nat Rev Immunol       Date:  2014-01-21       Impact factor: 53.106

View more
  59 in total

Review 1.  Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.

Authors:  Olivia Giddings; Charles R Esther
Journal:  Pediatr Pulmonol       Date:  2017-07-17

2.  Single-Cell Transcriptional Archetypes of Airway Inflammation in Cystic Fibrosis.

Authors:  Jonas C Schupp; Sara Khanal; Jose L Gomez; Maor Sauler; Taylor S Adams; Geoffrey L Chupp; Xiting Yan; Sergio Poli; Yujiao Zhao; Ruth R Montgomery; Ivan O Rosas; Charles S Dela Cruz; Emanuela M Bruscia; Marie E Egan; Naftali Kaminski; Clemente J Britto
Journal:  Am J Respir Crit Care Med       Date:  2020-11-15       Impact factor: 21.405

3.  A Flow Cytometric Method for Isolating Cystic Fibrosis Airway Macrophages from Expectorated Sputum.

Authors:  Katherine B Hisert; W Conrad Liles; Anne M Manicone
Journal:  Am J Respir Cell Mol Biol       Date:  2019-07       Impact factor: 6.914

4.  Cells of Innate and Adaptive Immunity: A Matter of Class?

Authors:  Heiko Herwald; Arne Egesten
Journal:  J Innate Immun       Date:  2017-02-02       Impact factor: 7.349

5.  Lumacaftor (VX-809) restores the ability of CF macrophages to phagocytose and kill Pseudomonas aeruginosa.

Authors:  Roxanna Barnaby; Katja Koeppen; Amanda Nymon; Thomas H Hampton; Brent Berwin; Alix Ashare; Bruce A Stanton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-11-16       Impact factor: 5.464

6.  Treating Cystic Fibrosis with mRNA and CRISPR.

Authors:  Alejandro Da Silva Sanchez; Kalina Paunovska; Ana Cristian; James E Dahlman
Journal:  Hum Gene Ther       Date:  2020-09-08       Impact factor: 5.695

Review 7.  Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.

Authors:  Claire Healy; Natalia Munoz-Wolf; Janné Strydom; Lynne Faherty; Niamh C Williams; Sarah Kenny; Seamas C Donnelly; Suzanne M Cloonan
Journal:  Respir Res       Date:  2021-04-29

Review 8.  Innate Immunity of the Lung: From Basic Mechanisms to Translational Medicine.

Authors:  Dominik Hartl; Rabindra Tirouvanziam; Julie Laval; Catherine M Greene; David Habiel; Lokesh Sharma; Ali Önder Yildirim; Charles S Dela Cruz; Cory M Hogaboam
Journal:  J Innate Immun       Date:  2018-02-13       Impact factor: 7.349

9.  Extracellular Vesicles from Pseudomonas aeruginosa Suppress MHC-Related Molecules in Human Lung Macrophages.

Authors:  David A Armstrong; Min Kyung Lee; Haley F Hazlett; John A Dessaint; Diane L Mellinger; Daniel S Aridgides; Gregory M Hendricks; Moemen A K Abdalla; Brock C Christensen; Alix Ashare
Journal:  Immunohorizons       Date:  2020-08-20

10.  Enhancing Cystic Fibrosis Immune Regulation.

Authors:  Anna M van Heeckeren; Morgan T Sutton; David R Fletcher; Craig A Hodges; Arnold I Caplan; Tracey L Bonfield
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.